Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG) and LivaNova (LIVN)

LivaNova to Announce First-Quarter 2024 Results

Analysts Have Conflicting Sentiments on These Healthcare Companies: LivaNova (LIVN), Vor Biopharma (VOR) and Neurogene (NGNE)

LivaNova (LIVN) Soars 12.5%: Is Further Upside Left in the Stock?

LivaNova (LIVN) Soars 12.5%: Is Further Upside Left in the Stock?

LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea

Returns On Capital Signal Difficult Times Ahead For LivaNova (NASDAQ:LIVN)

LivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029